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Abstract
Purpose: To present rare benign orbital tumors with bone destruction in children who could not be diagnosed pre-
surgically and may simulate malignant ones.
Methods: A retrospective review of cases. Clinical, operative and pathological records in all children with a diagnosis of
benign orbital tumors who showed remarkable bone destruction at a tertiary Ophthalmic Center in China between Jan 1,
2000 and Dec 31, 2009 were reviewed. All patients had definitive histopathologic diagnosis.
Results: Eight patients with benign orbital tumors showed obvious bone destruction, including six cases of eosinophilic
granuloma, one case of leiomyoma and one case of primary orbital intraosseous hemangioma. Among them, three patients
were females and five patients were males. Tumors were unilateral in all cases, with both the right and left side affected
equally. Age ranged from 3 to 7 years (mean 4.1 years). Symptom duration ranged from 1 to 5 weeks (mean 4.8 weeks).
Eyelid swelling and palpable mass were the most common complaint. There was no evidence for multifocal involvement in
cases with eosinophilic granuloma. Among six patients with eosinophilic granuloma, two were treated with low dose
radiation (10 Gy), three received systemic corticosteroid and one was periodically observed only after incisional biopsy or
subtotal curettage. There was no postoperative therapeutic intervention in the two patients with leiomyoma and
intraosseous hemangioma. All eight patients regained normal vision without local recurrence after a mean follow-up time of
32.8 months.
Conclusion: Benign orbital tumors such as isolated eosinophilic granuloma, leiomyoma and primary orbital intraosseous
hemangioma may show remarkable bone destruction.
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Introduction
In childhood, a large number of lesions can potentially cause
bone destruction of the bony orbit with or without a solid soft
tissue component. The most common benign tumor is the
dermoid inclusion cyst, others such as fibrous dysplasia, juvenile
ossifying fibroma are relatively common too [1]. All of these
benign masses have some distinctive clinical features and can be
easily diagnosed pre-surgically in clinical practice. Rhabdomyo-
sarcoma, myelogenous leukemia, neuroblastoma and osteosarco-
ma are the common malignant lesions which may demonstrate
bone destruction of the orbit in children [1,2,3]. However, some
benign tumors with orbital bone destruction, though uncommon,
could not be diagnosed pre-surgically and may simulate malignant
ones, which can strongly bias doctor’s decision-making in dealing
with the disease. Here, authors present their patients who show
remarkable bone destruction with a diagnosis of benign orbital
tumors.
Methods
Authors performed a retrospective review of patients with a
diagnosis of benign orbital tumors which showed remarkable bone
destruction in computed tomography scan and were treated at
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guang-
zhou, China between Jan 1, 2000 and Dec 31, 2009. The ethics
committee of Zhongshan Ophthalmic Center approved this
retrospective study and our paper has been conducted according
to the principles expressed in the Declaration of Helsinki. The
committee specifically waived the need for consent. The persons
concerned (or their legal guardians) have seen this manuscript and
figures and have provided written consent for publication. The
clinical, operative and pathological records were reviewed, and
orbital CT scans were examined. All patients had definitive
histopathologic diagnosis, with all histologic patterns reexamined
by two observers without knowledge of the previous diagnosis and
clinical outcome. Among the inclusion criteria were that all
patients had treatment by a single surgeon (JH Yan); systemic
evaluation by a pediatric oncologist, including a complete medical
history and physical examination, laboratory studies, and a bone
scan; and minimum follow-up of 12 months.
The data collected in this study included the general data such
as the patient’s age, sex, the duration of orbital lesion at
presentation. The ocular data included the affected orbit,
laterality, symptoms (visual problem, red or swelling, proptosis,
diplopia, palpable mass), signs (the best corrected vision, proptosis,
ocular motility deficit, strabismus). Tumor data included orbital
location (superior, inferior, anterior, posterior), configuration
(round, ovoid, diffuse), size, margin (ill-defined, well-defined),
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spaces involved, imaging findings, histopathologic examination.
All patients had a presumed diagnosis of orbital malignancy
before surgery. Usually, initial management involved incisional
biopsy or subtotal curettage. This generally was accomplished
through anterior orbitotomy. Tissue was submitted for patholog-
ical evaluation. After pathological diagnosis, the postoperative
treatment included close follow-up observation, low-dose irradia-
tion, or systemic corticosteroid.
Results
Eight patients met the inclusion criteria for this study (Table 1).
Among them, 5 patients were female and 5 male and none had a
previous history of serious illness. Involvement was unilateral in all
cases, with both the right and left side affected in four cases. Age at
time of first diagnosis ranged from 3 to 7 years (mean 4.1 years).
Symptom duration ranged from 1 to 5 weeks (mean 4.8 weeks).
Eyelid swelling and palpable mass was the most common
complaint; four of eight patients reported pain or tenderness.
Vision was mildly decreased in three patients. All patients
underwent incisional biopsy or subtotal curettage. However, the
curettage of grossly abnormal tissue was limited to the orbital
components, and abnormal tissue was not pursued into the
epidural space, temporal fossa, or forehead.
The histopathological examinations of specimens were sugges-
tive of eosinophilic granuloma in 6 cases, and leiomyoma and
primary orbital intraosseous hemangioma in 1 case respectively.
Light microscopic examination of formalin-fixed specimens
showed fairly uniform findings in patients with eosinophilic
granuloma. The tumor tissues were comprised of pathologic
Langerhans cells, eosinophils, scattered lymphocytes, plasma cells,
and multinucleated giant cells. Immunohistochemical stainings for
CD68, vimentin and S-100 were strongly positive in all 6 cases. In
patient with leiomyoma, the histopathologic examination showed
that the tumor was composed of spindle-shaped, benign-appearing
cells organized in fascicles or loosely arranged in a myxoid stroma.
In immunohistochemical staining, the specimen was positive for
vimentin and alpha-smooth muscle actin, negative for S-100. The
histopathologic finding of primary orbital intraosseous hemangi-
oma was straightforward, consisting of the thin-walled blood
vessels which are closely clustered and separated by normal bony
tissue (Figure 1–3). After pathologic diagnosis, all patients with
eosinophilic granuloma were evaluated by pediatric oncologists for
systemic involvement. Every patient underwent a complete
physical examination, routine laboratory testing, and radiographic
skeletal survey. Other evaluation varied and included radionuclide
bone scanning, abdominal and pelvic CT examination, blood
chemistry and bone marrow aspiration. There was no evidence for
multifocal Langerhans cell histiocytosis (LCH) in any case.
Following definitive diagnosis, in six patients with eosinophilic
granuloma, two patient were treated with fractionated external
beam radiation to total doses of 10 Gy, three patients received
systemic corticosteroid and one patients was periodically observed
only. Authors usually choose the course of systemic corticosteroids
as follows: Starting drug was dexamethasone 0.2 mg/kg per day
for 3 days. Then they used oral prednisone 1 mg/kg per day for
two weeks, and tapered slowly for two to three months. They did
not use local intralesional corticosteroids for their patients. There
was no postoperative therapeutic intervention in the two patients
with leiomyoma and primary orbital intraosseous hemangioma.
To authors’ surprise, all eight patients were doing quite well after
treatment. None of the 6 patients with eosinophilic granuloma had
local recurrence, other foci of LCH, or other serious illness. The 2
patients with leiomyoma and primary orbital intraosseous
hemangioma had no recurrence too. All 8 patients regained
Table 1. The clinical data in 8 cases of benign orbital tumors with bone destructions in children.
Case/Age(yr)/Sex/Side
Diagnosis
Symptoms/
Duration(wk) Physical findings CT findings Intervention Follow-up Outcome
1/3/M/R
Eosinophilic granuloma
Eyelid swelling/5;
pain
Upper eyelidedema;
erythema;
palpable mass
Low-density lesion;
extensive destruction of
anterolateral frontal bone
Incisional biopsy 20 m No other foci
no recurrence
normal vision
2/3/F/L
Eosinophilic granuloma
Eyelid swelling/4;
ptosis
Upper eyelid edema;
ptosis;
palpable mass
Superior-temporal mass;
bone destruction of anterior
frontal bone
Incisional biopsy
10 Gy radio
18 m No other foci
no recurrence
normal vision
3/7/M/R
Eosinophilic granuloma
Eyelid swelling/1;
pain;proptosis
decreased vision
Upper eyelid edema;
erythema;
tenderness
Lateral soft tissue mass;
bone destruction
of lateral wall
Subtotal curettage
10 Gy radio
60 m No other foci
no recurrence
normal vision
4/3/M/R
Eosinophilic granuloma
Eyelid swelling/3;
pain
Upper eyelid edema;
erythema;
tenderness
Superior soft tissue mass;
bone destruction of anterior
frontal bone
Subtotal curettage
systemic
corticosteroid
36 m No other foci
no recurrence
normal vision
5/5/F/L
Eosinophilic granuloma
Eyelid swelling/4;
proptosis
decreased vision
Lower eyelid edema;
erythema;
tenderness;
palpable mass
Inferior-temporal mass;
bone destruction of lateral
and lower wall
Subtotal curettage
systemic
corticosteroid
32 m No other foci
no recurrence
normal vision
6/6/M/L
Eosinophilic granuloma
Eyelid swelling/5;
decreased vision
Upper eyelid edema;
palpable mass
Superior-temporal mass;
extensive destruction of
anterolateral frontal bone
Subtotal curettage
systemic
corticosteroid
24 m No other foci
no recurrence
normal vision
7/3/F/L
Leiomyoma
Lateral orbital
lump/4
Palpable mass Lateral soft tissue mass;
bone destruction of lateral
wall
Subtotal curettage 36 m No recurrence
normal vision
8/3/M/R
Intraosseous hemangioma
Lower orbital
lump/4
Lower eyelid edema;
palpable mass
Inferior soft tissue mass;
bone destruction of lower
orbital wall
Subtotal curettage 36 m No recurrence
normal vision
doi:10.1371/journal.pone.0032111.t001
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18 months to 60 months).
Discussion
Both benign and malignant masses of the orbit can have bone
destruction [4]. Rarely, even orbital cavernous hemangioma may
have bone erosion [5]. However, the benign lesions with bone
destruction usually have definite clinical features and imaging
appearances which may help clinician to differentiate them from
maligancies. The dermoid cysts usually contain lipid and most
often lie near the zygomaticofrontal suture, with an indolent-
appearing erosion of bone. Fibrous dysplasia is a mass having a
characteristic of ground-glass appearance, whereas juvenile
ossifying fibroma is likely to produce a mixed lytic and sclerotic
lesion and focal osseous enlargement [1]. Authors found several
pediatric patients with patholoigcally confirmed benign lesions of
the orbit who revealed remarkable bone destruction at imaging
evaluation, really similar to malignant tumors.
Eosinophilic granuloma of the orbit is a subtype of Langerhans
cell histiocytosis (LCH), an idiopathic reticuloendothelial prolifer-
Figure 1. A–C: Patient with orbital eosinophilic granuloma
(case4). Figure 1A: Clinical appearance of fullness of the upper eyelid
of the right eye. Figure 1B: Computed tomography (CT) shows erosion
of an intraorbital soft tissue mass through anterior and posterior cortex
of frontal bone, similar to malignant tumors. Figure 1C: The tumor
tissues comprised pathologic Langerhans cells, eosinophils, scat-tered
lymphocytes, plasma cells, and multinucleated giant cells (magnification
6400; hematoxylin-eosin stain).
doi:10.1371/journal.pone.0032111.g001
Figure 2. A–E: Patient with orbital leiomyoma(case7). Figure 2A:
Clinical appearance of a hard, un-movable, well-marginated mass
measuring 15 mm610 mm in the left temporal periorbital area. Figure
2B, C: Computed tomography (Axial, Figure 2B; Coronal, Figure 2C)
revealed a 22 mm613 mm well-defined soft tissue mass. There was
marked destruction of the lateral orbital wall. Figure 2D: The
histopathologic examination showed that the tumor composed of
spindle-shaped, benign-appearing cells organized in fascicles or loosely
arranged in a myxoid stroma (magnification 6200; hematoxylin-eosin
stain). Figure 2E: In immunohistochemical staining, the specimen was
positive for alpha-smooth muscle actin (magnification 6200).
doi:10.1371/journal.pone.0032111.g002
Benign Tumors with Bone Destruction
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e32111ative disorder with clonal proliferative Langerhans cells. LCH
embraces three main clinical subtypes (or syndromes): Unifocal
eosinophilic granuloma disease, multifocal unisystem disease
(Hand–Schu ¨ller–Christian syndrome) and multifocal multisystem
disease (Letterer–Siwe syndrome). The isolated eosinophilic
granuloma of the orbit is uncommon, with onset in the first or
second decade, but predominantly in the 2–5 years age group.
Males are affected twice as frequently as females [6]. Symptoms
include rapidly progressive upper eyelid edema and erythema,
bone pain, and tenderness. The process usually involves the bones
of the lateral orbital roof; it produces lytic destruction of bone with
a sclerotic rim and a large intraorbital soft-tissue mass. Computed
tomography (CT) shows extensive frontal bone destruction, similar
to malignant tumors. The MRI appearance of orbital eosinophilic
granuloma usually was an isointensity mass on T1-weighted
images and a high-intensity mass on T2 weighted images. Gd-
DTPA clearly demonstrated the tumor extension. However, it
really suggests a benign and self-limiting problem and requires
biopsy and curettage only or combines with local or systemic
corticosteroids [6,7,8]. Because the Langerhans cells produced
cytokines IL-1 and PGE2, the disproportionate bone destruction
appeared. As the major osteoclast-activating factor and a potent
inhibitor of bone formation, IL-1 also interfered with collagen
synthesis [9,10]. It was reported in vitro bone resorption resulted
from PGE2 [11]. It seems that pathologic Langerhans cells lead to
osteolysis through the elaboration of PGE2 and IL-1 [6]. The
definitive diagnosis of orbital eosinophilic granuloma is in view of
identification of Langerhans cells, varying numbers of eosinophils,
mononuclear, multinucleated histiocytes, neutrophils and small
lymphocytes [6,7,8]. All patients need systemic investigation to
eliminate involvement of other organs.
Leiomyoma is a benign smooth muscle tumor that is most
commonly encountered in the uterus, skin, and gastrointestinal
tracts [12,13]. Leiomyomas of the orbit are very rare. To our
knowledge, bone destruction is an unreported presentation of an
orbital leiomyoma. The tumor is presumably derived from smooth
muscle cells of vessel walls posteriorly and from the capsulopal-
pebral or Mu ¨ller muscle anteriorly [12]. Arat et al recently
reviewed 26 cases of orbital leiomyoma [13]. The age of the
patients ranged from 9 years to 57 years (mean 30 years). Review
of previously reported cases showed a male predilection (73%)
[12,13,14]. The most common clinical presentation is a painless,
slowly progressing proptosis over several months or years, without
inflammation or pain that can be located anywhere in the orbit.
Leiomyomas located in the anterior orbit may present with
progressive painless swelling of the eyelids. The tumor can disturb
extraocular motility in some cases. Computed tomography (CT)
and MRI usually demonstrate a well-circumscribed orbital tumor.
On MRI, orbital leiomyoma was isointense to the extraocular
muscle on T1-weighted images and hyperintense on T2-weighted
images, with moderate contrast enhancement. However, there are
no specific characteristics which are helpful to radiologist for
excluding other benign orbital lesions [12,13,14,15,16]. Therefore
complete excision often has been chosen as the therapy [14].
Intimate follow-up is necessary, if without complete excision of
mass. The tumor is resistant to radiation which is not suggested in
orbital tumor [13]. Although it grew relatively fast and
demonstrated remarkable bone destruction, the tumor of our case
was deemed benign because it grew without malignant features
(such as high mitotic count and significant cellular atypia). In
immunohistochemical staining, the specimen was positive for
vimentin and alpha-smooth muscle actin, negative for S-100. The
post-operative course was uneventful. At the present time, 3 years
after surgery, the patient is currently doing well, without evidence
of recurrent disease, confirmed the diagnosis of leiomyoma, not
leiomyosarcoma. Erosion of adjacent bone due to secondary
compression phenomenon of vascular leiomyoma in other organs
has rarely been reported in the literature [17,18]. The mechanism
is worth of further investigation.
Primary intraosseous hemangiomas are rare, usually solitary,
benign, slow-growing neoplasms, with more than 50% being
found in the vertebra or skull. Primary orbital intraosseous
hemangiomas are extremely rare, only 45 cases were reported in
the English literature to date [19]. The pathogenesis of these
lesions is unknown. They are typically found in adults and occur
more frequently in females than males with a ratio of 3 to 1. The
two histologic types (cavernous and capillary) have similar imaging
findings and are often differentiated by their histopathologic
appearances. Plain radiographs demonstrates osteolytic lesion.
Heterogeneous internal structures with honeycomb pattern and
well-defined margins appear in CT scans. A sunburst of radiating
trabecula with or without a thin peripheral sclerotic rim is the
characteristic radiographic pattern [20,21]. Patients may have
signs with an asymptomatic lump, proptosis, diplopia, optic
atrophy, and ptosis. Clinical differential diagnosis involves
eosinophilic granuloma, fibrous dysplasia, osteoma, meningioma,
Figure 3. A–D: Patient with primary orbital intraosseous
hemangioma complicated with hematoma (case8). Figure 3A:
Clinical appearance of lower eyelid mass with obvious upward
displacement of the right eye. Figure 3B, C: Computed tomography
scan (Axial, Figure 3B; Sagittal, Figure 3C) disclosed a smoothly outlined
homogeneous soft tissue mass in the inferior-anterior part of the right
orbit, with remarkable bone destruction of the lower orbital rim. Figure
3D: The histopathologic finding of primary orbital intraosseous
hemangioma, consisting of the thin-walled blood vessels which are
closely clustered and separated by normal bony tissue (magnification
6200; hematoxylin-eosin stain).
doi:10.1371/journal.pone.0032111.g003
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may has obvious lesion without any symptoms. Otherwise, the
necessary therapy is complete excision, but partial excision may
lead to good result [21]. Authors’ case has some unusual clinical
features, such as the rapid onset of symptoms, complicated with a
hematoma in the anterior orbit, in a patient with hemophilia, age
at presentation, capillary type of hemangioma, only occurring at
the orbital rim. The lesion exhibited remarkable bone destruction
with round soft tissue mass on CT scan, mimicking the
characteristics of a malignant lesion, so that the lesion was
presumed to be orbital rhabdomyosarcoma pre-surgically. Follow-
up examination performed 3 years after discharge revealed no
recurrence of the tumor, and he has remained symptom free.
The differential diagnosis of benign orbital tumors with
prominent bone destruction in children that simulate malignant
tumors includes myofibroma, solitary fibrous tumors, haemangio-
pericytoma and so on. Orbit myofibroma typically occurs in
childhood and presents as a firm, painless, well-circumscribed
mass. Intraosseous occurance has been reported [22,23]. Although
histologically benign, lesions can be locally aggressive and
demonstrate rapid growth and irregular osseous destruction [22].
Treatment consists of complete surgical excision. Histologically,
myofibromas demonstrate a nodular arrangement of whorled,
interlacing bundles of myofibroblasts. These cells blend into a
central zone composed of less differentiated polygonal cells
arranged around vascular channels [22]. Myofibroma is immu-
nohistochemically positive for vimentin and smooth muscle actin
and negative for desmin, CD34, S100 [22,23,24]. The solitary
fibrous tumor (SFT) is an uncommon spindle-cell neoplasms of
orbit and usually shows a slow-growing, painless extraconal lesion.
It occurs over a wide age range, including children. CT and MRI
usually reveal round to oval, well-circumscribed, contrast-enhanc-
ing lesions that may or may not cause bony erosion. Cytologic
atypia, increased mitotic activity, and increased prognostic marker
reactivity can identify histologically borderline or low-grade
malignant ocular SFT [25]. Treatment of SFT includes complete
surgical removal. Tumor cells are described as spindle shaped with
scant cytoplasm and indistinct nucleoli. The tumor matrix
contains a distinctive thick ‘‘ropey’’ type of collagen between the
randomly oriented tumor cells. Immunohistochemically, these
neoplasms are consistently immunoreactive for vimentin, CD34
and CD99, but negative for desmin and actin [26,27]. Heman-
giopericytomas(HPCs) are uncommon vascular tumors composed
of an abnormal proliferation of pericytes. They usually occur in
adults, but it has been noted in children [24,26]. The major
clinical features of orbital HPCs are proptosis and either
extraconal or intraconal mass effect, but predominantly in the
superior orbit, with bone erosion sometimes. On CT and MRI
imaging, these tumors tend to present as well-defined masses with
remarkable homogeneous enhancement. They have an unpre-
dictable pattern of behavior and best handled by careful local
excision [26,28]. Under the microscope, HPCs are remarkable for
their characteristic thin-walled, branching or ‘‘staghorn’’ blood
vessels, with closely packed, randomly oriented cells and irregular,
carrot-shaped nuclei. Mitotic activity and nuclear atypia are
considered predictive of aggressive behavior. HPCs are diffusely
immunoreactive for vimentin and CD34, but negative for S-100
protein [26]. Recently some authors proposed that orbital HPC
can justifiably be redesignated as orbital SFT; they have a
spectrum of overlapping morphologic and immunophenotypic
findings suggestive of the previously subcategorized diagnoses
[27,28,29].
In summary, some benign orbital tumors, including isolated
eosinophilic granuloma, leiomyoma and primary orbital intra-
osseous hemangioma may show remarkable bone destruction in
children. Therefore, we should pay attention to these rare orbital
benign tumors in the differentiation of tumors with bone
destruction. The differential diagnosis includes myofibroma,
solitary fibrous tumors, haemangiopericytoma and so on.
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